Targeting EMSY-Mediated Methionine Metabolism Is a Potential Therapeutic Strategy for Triple-Negative Breast Cancer

Researchers discovered that EMSY, inducing a BRCAness phenotype, was preferentially expressed in breast CSCs, promoted ALDH+ cells enrichment, and was positively correlated with poor relapse-free survival.